Big Changes Kicking In Under Australia’s Personalized Medical Devices Rules
Executive Summary
Most of the products currently supplied under Australia’s custom-made medical device exemption will no longer be eligible for supply in this way.
You may also be interested in...
Australia Tries Again At Tightening Personalized And 3D-Printed Device Rules
The Therapeutics Goods Administration has begun a second public consultation on how it intends to improve its rules for 3D-printed and other personalized medical devices after stakeholders called for more clarification to proposals made in 2017.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
Moment Of Truth For Seven EU Filings; Cytokinetics To Make Its Case For Heart Failure Drug
The CHMP, the European Medicines Agency’s human medicines committee, will this week decide whether a range of new medicines merit being approved.